Literature DB >> 10623848

Characterization of CD4+ T cell responses during natural infection with Salmonella typhimurium.

S J McSorley1, B T Cookson, M K Jenkins.   

Abstract

CD4+ T cells are important for resistance to infection with Salmonella typhimurium. However, the Ag specificity of this T cell response is unknown. Here, we demonstrate that a significant fraction of Salmonella-specific CD4+ T cells respond to the flagellar filament protein, FliC, and that this Ag has the capacity to protect naive mice from lethal Salmonella infection. To characterize this Ag-specific response further, we generated FliC-specific CD4+ T cell clones from mice that had resolved infection with an attenuated strain of Salmonella. These clones were found to respond to an epitope from a constant region of FliC, enabling them to cross-react with flagellar proteins expressed by a number of distinct Salmonella serovars.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10623848     DOI: 10.4049/jimmunol.164.2.986

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  100 in total

1.  Extracellular antigens from Salmonella enteritidis induce effective immune response in mice after oral vaccination.

Authors:  Lena Strindelius; Lena Degling Wikingsson; Ingvar Sjöholm
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

2.  CD4+ T cell epitopes of FliC conserved between strains of Burkholderia: implications for vaccines against melioidosis and cepacia complex in cystic fibrosis.

Authors:  Julie A Musson; Catherine J Reynolds; Darawan Rinchai; Arnone Nithichanon; Prasong Khaenam; Emmanuel Favry; Natasha Spink; Karen K Y Chu; Anthony De Soyza; Gregory J Bancroft; Ganjana Lertmemongkolchai; Bernard Maillere; Rosemary J Boyton; Daniel M Altmann; John H Robinson
Journal:  J Immunol       Date:  2014-11-12       Impact factor: 5.422

3.  Antigen selection based on expression levels during infection facilitates vaccine development for an intracellular pathogen.

Authors:  Claudia Rollenhagen; Meike Sörensen; Konstantin Rizos; Robert Hurvitz; Dirk Bumann
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-01       Impact factor: 11.205

4.  Salmonella flagellin is not a dominant protective antigen in oral immunization with attenuated live vaccine strains.

Authors:  Chie Kodama; Hidenori Matsui
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

5.  Selective culling of high avidity antigen-specific CD4+ T cells after virulent Salmonella infection.

Authors:  James M Ertelt; Tanner M Johanns; Margaret A Mysz; Minelva R Nanton; Jared H Rowe; Marijo N Aguilera; Sing Sing Way
Journal:  Immunology       Date:  2011-12       Impact factor: 7.397

6.  Vaccination with a single CD4 T cell peptide epitope from a Salmonella type III-secreted effector protein provides protection against lethal infection.

Authors:  Jonathan R Kurtz; Hailey E Petersen; Daniel R Frederick; Lisa A Morici; James B McLachlan
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

7.  TLR5 functions as an endocytic receptor to enhance flagellin-specific adaptive immunity.

Authors:  Shirdi E Letran; Seung-Joo Lee; Shaikh M Atif; Satoshi Uematsu; Shizuo Akira; Stephen J McSorley
Journal:  Eur J Immunol       Date:  2010-12-03       Impact factor: 5.532

Review 8.  Tracking the dynamics of T-cell activation in response to Salmonella infection.

Authors:  Rajesh Ravindran; Stephen J McSorley
Journal:  Immunology       Date:  2005-04       Impact factor: 7.397

9.  Influence of Slc11a1 on the outcome of Salmonella enterica serovar Enteritidis infection in mice is associated with Th polarization.

Authors:  Judith Caron; Line Larivière; Mayss Nacache; Mifong Tam; Mary M Stevenson; Colin McKerly; Philippe Gros; Danielle Malo
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

10.  MHC heterozygosity confers a selective advantage against multiple-strain infections.

Authors:  Dustin J Penn; Kristy Damjanovich; Wayne K Potts
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.